These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8738056)

  • 41. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis.
    Martinez-Vea A; Bardají A; García C; Ridao C; Richart C; Oliver JA
    Am J Kidney Dis; 1992 Apr; 19(4):353-7. PubMed ID: 1532883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemodynamic changes measured by transthoracic bioimpedance during treatment with recombinant human erythropoietin.
    Jones MA; Kingswood JC; Dallyn PE; Sharpstone P
    Clin Exp Hypertens; 1996 Jan; 18(1):51-64. PubMed ID: 8822233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
    Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
    Faller B; Slingeneyer A; Waller M; Michel C; Grützmacher P; Müller HP; Barany P; Grabensee B; Issad B; Schmitt H
    Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension as a possible complication of recombinant human erythropoietin therapy.
    Brunkhorst R; Nonnast-Daniel B; Koch KM; Frei U
    Contrib Nephrol; 1991; 88():118-25; discussion 126. PubMed ID: 2040173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.
    Van Damme-Lombaerts R; Broyer M; Businger J; Baldauf C; Stocker H
    Pediatr Nephrol; 1994 Jun; 8(3):338-42. PubMed ID: 7917862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia.
    Tomoda F; Takata M; Izumino K; Oh-hashi S; Ueno H; Iida H
    Nephron; 1994; 66(3):307-11. PubMed ID: 8190183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Erythropoietin and hypertension].
    Frei U; Nonnast-Daniel B; Koch KM
    Klin Wochenschr; 1988 Sep; 66(18):914-9. PubMed ID: 3054276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation.
    Nonnast-Daniel B; Creutzig A; Kühn K; Bahlmann J; Reimers E; Brunkhorst R; Caspary L; Koch KM
    Contrib Nephrol; 1988; 66():185-94. PubMed ID: 3292147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
    Zappacosta AR; Perras ST; Bell A
    Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
    Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
    Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis.
    Macdougall IC; Matcham J; Gray SJ;
    Nephrol Dial Transplant; 2003 Mar; 18(3):576-81. PubMed ID: 12584282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.